Another day of Wall Street confusion today. President Trump was pictured coughing, a bad sign, while he was threatening to hit the campaign trail in person tomorrow, allegedly with medical permission. Meanwhile, he is playing tough on another round of talks about stimulus and has vetoed participating in a virtual debate. He is also attacking members of his own team for failing to reveal Hillary Clinton's emails which allegedly were illegal. He called Democrat vice-president Kamala Harris “a Communist”.

While El Presidente has a long record of tweeting irresponsibly, I think his latest pileup of charges against his own Secretary of State, Treasury Secretary, and cabinet members is a signal that his treatment with Remdesivir or steroids or antibodies or another potion has led to a psychological crisis in the White House patient. He is ranting against his strongest loyalists. He also reversed his earlier negativism by talking about a “big deal on stimulus”.

It doesn't help that Regeneron and similar antibody treatments for COVID-19 use tissues from aborted fetuses to grow the antibodies, creating a gap between hope and ideology in the Republican camp.

Marking the end of Golden Week, China saw its yuan (or renminbi) rise to a new 4-yr high against the greenback, $6.6929. This is not only about economics, but also about political stability, another result of the Trump barrage. More on China below.

More for paid subscribers follows. We have a family visit for lunch and the blog with be short.

Yield plays

Given the worries about a crackdown on tech monopolies, I think growth is high risk in the runoff to the election. Time to go for income positions.

*Today there was a 6.5% drop in the price of Atlantica Yield which was tipped earlier this week by one of our writers. It was compared to Algonquin Power & Utilities (AQN) which holds about 44% of AY. He liked the tax edge from AY but its drop today he says is because it rose too fast. It was downgraded to neutral by BofA.

*Our two Aberdeen funds (run by Standard Life Aberdeen, the Scottish insurer-fund manager whose stock I tip) Aberdeen Asia Pacific Income Fund (FAX) and Aberdeen Global Income Fund (FCO) will announce their dividends today. FAX rose 0.25% after its divvie but FCO was flat.

*Lazard Global Total Return Fund LGI will reveal its dividend on Nov. 15^th. LGI is a stock fund but also has a nice yield.

*Banco Latino-Americana de Comercio Exterior fell 3% on going ex-div. BLX is a Panama multilateral trade finance funder with govt, bank, and retail investor owners.

Other stocks

*Canadian Solar is today's best performer up 5.4% to $41.55 on hopes for carbon control worldwide. Despite its name it mainly operates in China. Danke schoen Max Deml fuer GSIQ.

*Royal Dutch Shell B RDS-B is up 1.55% to $25.87. BP plc BP fell 0.34% to $17.43. This is possibly a reaction to their differing short-term risks from Hurricane Delta according to analysis from Zacks of Chicago.

*Ormat Tech ORA, the Israeli-owned geothermal energy, and storage Nevada firm, gained 3% today because Israel is closed. It is pushing storage in California to cover periods when solar or wind are down.

*GE is up another 3.7% to $6.89 on the Goldman Sachs recommendation and forecast of a 50% return.

*Bonus stock Qualcomm is up but given the shakeout in its sector, it may not be overpriced according to Benzinga. At $125 up 3.35% today I would not buy QCOM.

*Microsoft MSFT, not in the bad guy group designated as monopolies by the House investigation, is up 4%.

*Spider Gold, GLD, is up 1.35% from market fear over how Trump will handle an election loss.

*Also up is Kirkland Lake Gold, KL, up 3.8% despite BofA lowering its target price yesterday

*Spanish Grifols (GRFS) which works on antibodies, is up the most for drug dealers here, 5.1%.

*Astra-Zeneca AZN is up 1.31% to $54.4, nearly 16% below its year's high.

*Novo Nordisk is ahead 1.2% despite or because of the feeble class-action lawsuit claiming NVO exaggerated its market for diabetes—but failed to note its gains for obesity.

*Boosted by China deals on virus jabs, Beigene BGNE is up 2.65% today.

*With another long weekend in Israel, Compugen CGEN rose 2.7% here.

*Zymeworks ZYME which has a double-edge cancer drug is up 1%.

*Swiss Roche gained 2.33% on its good outlook in several drug sectors from cancer to HIV. RHHBY.

*NIO opened its Hefei offices and announced a partnership with Hefei Charge, a part of the city's investment arm, for leasing batteries which can then be recharged without delays for the next 2 years.

*Nokia rose 2% after Finnish NOK won a Belgian 5G network contract for Orange and Proximus cellphone systems, replacing Huawei.

*Vodafone VOD was written up by Tarek El-Sherbini as “an oasis of calm” and for its diversification into 23 markets.

*Mercado Libre MELI, the Latin American version of Amazon, is up 2.63% after falling yesterday. At $1191 it is near it high.

*Tomra Systems TMRAY of Norway gained nearly 4% as it is not very dependent on the US. It would gain if there is a Biden presidency or a drop in virus infections for its recycling machines and overall from its sorting systems for drugs, metals, trash, and other things.

*Nutrien NTR of Canada rose on hopes that a stimulus deal will let people buy more food so fertilizer and seeds it sells will go better

*UK food seller Greencore (GNCGY if Ireland), rose $1.75% today after it was downgraded yesterday because it is losing its lunchtime sandwich and take-home businesses as covid-19 leaves people working from home.

*South Africa's Naspers NPSNY is up 3.4% catching up with Prosus PROSY.